Rudy Ippodrino worked in gene therapy field, his studies have been focused on recombinant adeno-associated viral vectors.

He has obtained his Ph.D. (Molecular Biology) at the prestigious “Scuola Normale Superiore di Pisa” which ranks among the first universities worldwide.

His creativity, combined with his vocation for biotech innovation, pushed him to found Ulisse BioMed in order to generate high-tech platforms and to develop disruptive products that can transform modern medicine.